Barclays Maintains Overweight on Twist Bioscience, Lowers Price Target to $130

Benzinga · 1d ago
Barclays analyst Luke Sergott maintains Twist Bioscience (NASDAQ:TWST) with a Overweight and lowers the price target from $215 to $130.